2 min read Bus & Finance Aurobindo Pharma slips 17% as USFDA revokes VAI status for Unit-IV February 24, 2020 Williams Bova Shares of Aurobindo Pharma slipped 17 for every cent at Rs 498 on the BSE on Monday soon after in...